Skip to main content



Nov 23, 2021

At Janssen, we're creating a future where disease is a thing of the past. We're the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension. Learn more at Follow us at @Janssenanz.

> Media Contact
Email: [email protected]
This contact is only for journalists. If you are not a member of the media then please submit your query via

> News Press Releases
2 November, 2023
Download the Lung Cancer Patient Guidebook

31 May, 2023
New PBS listing for deadly, advanced prostate cancer

1 May, 2023
New PBS listing offers hope to Australian's with ulcerative colitis

16 May, 2022
Accelerating Access to Innovative Medicines

6 December, 2021
Getting Australia to the front of the queue

22 November, 2021
SPRAVATO® (esketamine hydrochloride) nasal spray is now available in Australia for treatment resistant depression

7 September, 2021
Statement from Janssen ANZ MD Biljana Naumovic in response to 5-year Strategic Agreement

Read More about our response to COVID

> 1 July 2021
TREMFYA® on the PBS for Australians with Active Psoriatic Arthritis